Stem Cell Therapeutic and Research Reauthorization Act of 2026
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill reauthorizes the Stem Cell Therapeutic and Research Act of 2005 by extending federal funding for stem cell research and therapy programs through fiscal year 2031. It increases annual appropriations for the C.W. Bill Young Cell Transplantation Program from $31.009 million to $33.009 million for fiscal years 2027–2031, and extends the authorization for the national cord blood inventory program by five years.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.